Tags: BreastCancer, Grants, Honors
Rachel Freedman commented on targeted treatments – those that attack a specific
characteristic of a cancer strain – becoming the norm in breast cancer care.
Dr. Mehra Golshan and Dr. Yasuaki Sagara led a study that showed surgery for a very early type of breast cancer does not significantly improve outcomes for patients.
Tags: BreastCancer, Radiation
Rachel Freedman led a study, published in CANCER, that found many women
with breast cancer may lack knowledge regarding their illness.
Tags: BreastCancer, Genomics
Tags: BreastCancer, OvarianCancer, GynecologicCancers
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: